149
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women

, , , , , , , & show all
Pages 863-872 | Published online: 10 Jun 2019

References

  • Vernon G , Baranova A , Younossi ZM . Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther . 2011;34(3):274–285. doi:10.1111/j.1365-2036.2011.04724.x 21623852
  • Gupta R , Bhangoo A , Matthews NA , et al. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab . 2011;24(11–12):907–911. doi:10.1515/JPEM.2011.282 22308841
  • Tominaga K , Fujimoto E , Suzuki K , Hayashi M , Ichikawa M , Inaba Y . Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med . 2009;14(2):142–149. doi:10.1007/s12199-008-0074-5 19568858
  • Younossi Z , Tacke F , Arrese M , et al. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology . 2018. doi:10.1002/hep.30251
  • Angulo P . GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther . 2007;25(8):883–889. doi:10.1111/j.1365-2036.2007.03246.x 17402991
  • Hagstrom H , Nasr P , Ekstedt M , et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol . 2017. doi:10.1016/j.jhep.2017.07.027
  • Milic S , Stimac D . Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis . 2012;30(2):158–162. doi:10.1159/000336669 22722431
  • Youssef W , McCullough AJ . Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis . 2002;13(1):17–30.11944630
  • Barrows BR , Parks EJ . Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab . 2006;91(4):1446–1452. doi:10.1210/jc.2005-1709 16449340
  • Kashyap S , Belfort R , Gastaldelli A , et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes . 2003;52(10):2461–2474.14514628
  • Polyzos SA , Kountouras J , Mantzoros CS . Adipokines in nonalcoholic fatty liver disease. Metabolism . 2016;65(8):1062–1079. doi:10.1016/j.metabol.2015.11.006 26725002
  • Kalupahana NS , Claycombe KJ , Moustaid-Moussa N . (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr . 2011;2(4):304–316. doi:10.3945/an.111.000505 22332072
  • Goldstein BJ . Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol . 2002;90(5a):3g–10g.
  • Samuel VT , Shulman GI . Nonalcoholic Fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab . 2018;27(1):22–41. doi:10.1016/j.cmet.2017.08.002
  • Browning JD , Szczepaniak LS , Dobbins R , et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology . 2004;40(6):1387–1395. doi:10.1002/hep.20466 15565570
  • Kim D , Kim WR . Nonobese fatty liver disease. Clin Gastroenterol Hepatol . 2017;15(4):474–485. doi:10.1016/j.cgh.2016.08.028 27581063
  • Fan JG , Kim SU , Wong VW . New trends on obesity and NAFLD in Asia. J Hepatol . 2017;67(4):862–873. doi:10.1016/j.jhep.2017.06.003 28642059
  • Katulanda P , Jayawardena MA , Sheriff MH , Constantine GR , Matthews DR . Prevalence of overweight and obesity in Sri Lankan adults. Obes Rev . 2010;11(11):751–756. doi:10.1111/j.1467-789X.2010.00746.x 20406417
  • Younossi ZM , Koenig AB , Abdelatif D , Fazel Y , Henry L , Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64(1):73–84. doi:10.1002/hep.28431 26707365
  • Deurenberg-Yap M , Schmidt G , van Staveren WA , Deurenberg P . The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord . 2000;24(8):1011–1017.10951540
  • Lear SA , Humphries KH , Kohli S , Chockalingam A , Frohlich JJ , Birmingham CL . Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr . 2007;86(2):353–359. doi:10.1093/ajcn/86.2.353 17684205
  • Ghosh A . Interrelationship of waist circumference and subcutaneous fat with metabolic and blood pressure measures among Asian Indian men. Anthropol Anz . 2007;65(1):75–85.17444193
  • McKeigue PM , Pierpoint T , Ferrie JE , Marmot MG . Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia . 1992;35(8):785–791.1511807
  • Misra A , Pandey RM , Sinha S , Guleria R , Sridhar V , Dudeja V . Receiver operating characteristics curve analysis of body fat & body mass index in dyslipidaemic Asian Indians. Indian J Med Res . 2003;117:170–179.14604306
  • Patel PJ , Banh X , Horsfall LU , et al. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Intern Med J . 2018;48(2):144–151.
  • Saadeh S , Younossi ZM , Remer EM , et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology . 2002;123(3):745–750.12198701
  • Aruni AW , Lee J , Osbourne D , et al. VimA-dependent modulation of acetyl coenzyme A levels and lipid A biosynthesis can alter virulence in Porphyromonas gingivalis. Infect Immun . 2012;80(2):550–564. doi:10.1128/IAI.06062-11 22144476
  • Hung AM , Sundell MB , Plotnikova NE , et al. A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis. J Ren Nutr . 2013;23(3):185–193. doi:10.1053/j.jrn.2012.06.005 22959781
  • Kirchner H , Nylen C , Laber S , et al. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. Surg Obes Relat Dis . 2014;10(4):671–678. doi:10.1016/j.soard.2013.12.019 24837562
  • Mujumdar PP , Duerksen-Hughes PJ , Firek AF , Hessinger DA . Long-term, progressive, aerobic training increases adiponectin in middle-aged, overweight, untrained males and females. Scand J Clin Lab Invest . 2011;71(2):101–107. doi:10.3109/00365513.2011.554995 21271804
  • Rastogi A , Shasthry SM , Agarwal A , et al. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study. APMIS . 2017;125(11):962–973. doi:10.1111/apm.12742 29076589
  • Kwak JH , Jun DW , Lee SM , et al. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. Clin Nutr . 2018;37(5):1550–1557.
  • Association AD. Classification and Diagnosis of Diabetes. Diabetes Care . 2017;40(Supplement 1):S11–S24. doi:10.2337/dc17-S005 27979889
  • Tillin T , Hughes AD , Wang Q , et al. Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study. Diabetologia . 2015;58(5):968–979. doi:10.1007/s00125-015-3517-8 25693751
  • Wu Y , Ma KL , Zhang Y , et al. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease. Liver Int . 2016;36(10):1525–1534. doi:10.1111/liv.13131 27028410
  • WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet . 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3 14726171
  • Forouhi NG . Ethnicity and the metabolic syndrome In: Byrne CD , Wild SH , editors. The Metabolic Syndrome . Chichester: Wiley; 2005:43–84.
  • Sniderman AD , Bhopal R , Prabhakaran D , Sarrafzadegan N , Tchernof A . Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol . 2007;36(1):220–225. doi:10.1093/ije/dyl245 17510078
  • Sniderman AD , Cianflone K , Arner P , Summers LK , Frayn KN . The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler Thromb Vasc Biol . 1998;18(2):147–151.9484977
  • Koska J , Stefan N , Permana PA , et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr . 2008;87(2):295–302. doi:10.1093/ajcn/87.2.295 18258617
  • Jayawardana R , Ranasinghe P , Sheriff MH , Matthews DR , Katulanda P . Waist to height ratio: a better anthropometric marker of diabetes and cardio-metabolic risks in South Asian adults. Diabetes Res Clin Pract . 2013;99(3):292–299. doi:10.1016/j.diabres.2012.12.013 23298662
  • Bilen O , Kamal A , Virani SS . Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: current state and future directions. World J Cardiol . 2016;8(3):247–257. doi:10.4330/wjc.v8.i3.247 27022456
  • Kalhan SC , Guo L , Edmison J , et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism . 2011;60(3):404–413. doi:10.1016/j.metabol.2010.03.006 20423748
  • Karthikeyan G , Teo KK , Islam S , et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol . 2009;53(3):244–253. doi:10.1016/j.jacc.2008.09.041 19147041
  • Gupta R , Gupta VP , Sarna M , et al. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur heart watch-2. Indian Heart J . 2002;54(1):59–66.11999090
  • Gupta R , Guptha S , Sharma KK , Gupta A , Deedwania P . Regional variations in cardiovascular risk factors in India: india heart watch. World J Cardiol . 2012;4(4):112–120. doi:10.4330/wjc.v4.i4.112 22558490
  • Papandreou C , Bullo M , Tinahones FJ , et al. Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial. Nutr Metab (Lond) . 2017;14:58. doi:10.1186/s12986-017-0213-3 28878811
  • Lucero D , Miksztowicz V , Gualano G , et al. Nonalcoholic fatty liver disease associated with metabolic syndrome: influence of liver fibrosis stages on characteristics of very low-density lipoproteins. Clin Chim Acta . 2017;473:1–8. doi:10.1016/j.cca.2017.08.006 28802640
  • Skurk T , Alberti-Huber C , Herder C , Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab . 2007;92(3):1023–1033. doi:10.1210/jc.2006-1055 17164304
  • Forouhi NG , Sattar N , McKeigue PM . Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord . 2001;25(9):1327–1331. doi:10.1038/sj.ijo.0801723 11571595
  • Park SH , Kim BI , Yun JW , et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol . 2004;19(6):694–698. doi:10.1111/j.1440-1746.2004.03362.x 15151626
  • Pagano C , Soardo G , Pilon C , et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab . 2006;91(3):1081–1086. doi:10.1210/jc.2005-1056 16394091
  • Wilfred de Alwis NM , Day CP . Genes and nonalcoholic fatty liver disease. Curr Diab Rep . 2008;8(2):156–163.18445359
  • Kloting N , Bluher M . Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord . 2014;15(4):277–287. doi:10.1007/s11154-014-9301-0 25344447
  • Wasim H , Al-Daghri NM , Chetty R , McTernan PG , Barnett AH , Kumar S . Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol . 2006;5:10. doi:10.1186/1475-2840-5-10 16669997
  • Arner P . The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab . 2003;14(3):137–145.12670740
  • Bokarewa M , Nagaev I , Dahlberg L , Smith U , Tarkowski A . Resistin, an adipokine with potent proinflammatory properties. J Immunol . 2005;174(9):5789–5795.15843582
  • Steppan CM , Bailey ST , Bhat S , et al. The hormone resistin links obesity to diabetes. Nature . 2001;409(6818):307–312. doi:10.1038/35053000 11201732
  • Muse ED , Obici S , Bhanot S , et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest . 2004;114(2):232–239. doi:10.1172/JCI21270 15254590
  • Murad A . HH, H Husein & A Ayad. Serum resistin levels in nonalcoholic fatty liver disease and their relationship to severity of liver disease. JEMDSA . 2010;15(1):53–55. doi:10.1080/22201009.2010.10872225
  • Chitturi S , Farrell GC . Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis . 2001;21(1):27–41.11296694
  • Rangwala SM , Rich AS , Rhoades B , et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes . 2004;53(8):1937–1941. 53.08.04.db04-0422 15189975
  • Banerjee RR , Rangwala SM , Shapiro JS , et al. Regulation of fasted blood glucose by resistin. Science . 2004;303(5661):1195–1198. doi:10.1126/science.1092341 14976316
  • Abd El-Kader SM , El-Den Ashmawy EM . Non-alcoholic fatty liver disease: the diagnosis and management. World J Hepatol . 2015;7(6):846–858. doi:10.4254/wjh.v7.i6.846 25937862
  • Ludwig J , Viggiano TR , McGill DB , Oh BJ . Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc . 1980;55(7):434–438.7382552
  • Abenavoli L , Greco M , Milic N , et al. Effect of mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients . 2017;9:8. doi:10.3390/nu9080870
  • Suarez M , Boque N , Del Bas JM , Mayneris-Perxachs J , Arola L , Caimari A . Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients . 2017;9:10. doi:10.3390/nu9101052